blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2464384

EP2464384 - SALT OF A PHOTOSENSITIZING AGENT FOR USE IN PHOTOCHEMICAL INTERNALIZATION [Right-click to bookmark this link]
Former [2012/25]PHOTOSENSITIZING COMPOSITIONS
[2016/19]
StatusNo opposition filed within time limit
Status updated on  18.08.2017
Database last updated on 26.12.2024
Most recent event   Tooltip10.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 12.08.2020  [2020/33]
Applicant(s)For all designated states
PCI Biotech AS
Ullernchausseen 64
0379 Oslo / NO
[2016/38]
Former [2012/25]For all designated states
PCI Biotech AS
Strandveien 55
1366 Lysaker / NO
Inventor(s)01 / KLAVENESS, Jo
Midtasen 5
N-1166 Oslo / NO
02 / HOGSET, Anders
PCI Biotech AS
Ullernchausseen 64
0379 Oslo / NO
 [2016/38]
Former [2012/25]01 / KLAVENESS, Jo
Midtasen 5
N-1166 Oslo / NO
02 / HOGSET, Anders
PCI Biotech AS
Strandveien 55
N-1366 Lysaker / NO
Representative(s)Golding, Louise Ann
Dehns
St Bride's House
10 Salisbury Square
London EC4Y 8JD / GB
[2016/41]
Former [2012/25]Golding, Louise Ann
Dehns St Bride's House 10 Salisbury Square London
EC4Y 8JD / GB
Application number, filing date10747249.016.08.2010
[2016/41]
WO2010GB01547
Priority number, dateGB2009001428714.08.2009         Original published format: GB 0914287
[2012/25]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2011018635
Date:17.02.2011
Language:EN
[2011/07]
Type: A2 Application without search report 
No.:EP2464384
Date:20.06.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 17.02.2011 takes the place of the publication of the European patent application.
[2012/25]
Type: B1 Patent specification 
No.:EP2464384
Date:12.10.2016
Language:EN
[2016/41]
Search report(s)International search report - published on:EP07.07.2011
ClassificationIPC:A61K41/00, A61K38/14, A61K9/00, A61P43/00, A61P35/00, A61K48/00, C12N15/87
[2016/19]
CPC:
A61K41/0071 (EP,KR,US); A61K9/0019 (KR); A61K9/08 (KR);
A61P35/00 (EP); A61P43/00 (EP); A61K2121/00 (KR)
Former IPC [2012/25]A61K41/00, A61K48/00, A61K9/00, A61P43/00, A61P35/00, C12N15/87
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/25]
Extension statesBA13.03.2012
ME13.03.2012
RS13.03.2012
TitleGerman:SALZ VON EINEM PHOTOSENSITIZER ZUR VERWENDUNG IN DER PHOTOCHEMISCHEN INTERNALISIERUNG[2016/19]
English:SALT OF A PHOTOSENSITIZING AGENT FOR USE IN PHOTOCHEMICAL INTERNALIZATION[2016/19]
French:SEL D'UN AGENT PHOTOSENSIBILISATEUR POUR UNE UTILISATION EN INTERNALISATION PHOTOCHIMIQUE[2016/19]
Former [2012/25]PHOTOSENSITIZER-ZUSAMMENSETZUNGEN
Former [2012/25]PHOTOSENSITIZING COMPOSITIONS
Former [2012/25]PROCÉDÉ D'INTERNALISATION PHOTOCHIMIQUE
Entry into regional phase13.03.2012National basic fee paid 
13.03.2012Designation fee(s) paid 
13.03.2012Examination fee paid 
Examination procedure13.03.2012Examination requested  [2012/25]
04.12.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
14.02.2013Amendment by applicant (claims and/or description)
03.08.2015Despatch of a communication from the examining division (Time limit: M06)
15.02.2016Reply to a communication from the examining division
20.04.2016Communication of intention to grant the patent
30.08.2016Fee for grant paid
30.08.2016Fee for publishing/printing paid
30.08.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  03.08.2015
Opposition(s)13.07.2017No opposition filed within time limit [2017/38]
Request for further processing for:14.02.2013Request for further processing filed
14.02.2013Full payment received (date of receipt of payment)
Request granted
19.03.2013Decision despatched
Fees paidRenewal fee
20.08.2012Renewal fee patent year 03
23.08.2013Renewal fee patent year 04
19.08.2014Renewal fee patent year 05
18.08.2015Renewal fee patent year 06
19.08.2016Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU16.08.2010
AL12.10.2016
CY12.10.2016
EE12.10.2016
SM12.10.2016
BG12.01.2017
GR13.01.2017
IS12.02.2017
[2020/33]
Former [2019/46]HU16.08.2010
CY12.10.2016
EE12.10.2016
SM12.10.2016
BG12.01.2017
GR13.01.2017
IS12.02.2017
Former [2019/31]HU16.08.2010
EE12.10.2016
SM12.10.2016
BG12.01.2017
GR13.01.2017
IS12.02.2017
Former [2017/43]EE12.10.2016
SM12.10.2016
BG12.01.2017
GR13.01.2017
IS12.02.2017
Former [2017/29]GR13.01.2017
IS12.02.2017
Cited inInternational search[XDYI]WO03020309  (NORWEGIAN RADIUM HOSPITAL RES [NO], et al) [XD] 1-7,10-16 * page 5, formula (I) * * page 11, lines 9-15 * * page 14, paragraphs 2,3 * * page 15, paragraphs 2,3 * * page 16, lines 16-18 * * page 18, lines 14-34 * * examples 1,2 * * claims 4,8,16,18,20,21,26,27 * [Y] 4 [I] 8,9;
 [XPI]WO2010001102  (PCI BIOTECH AS [NO], et al) [XP] 1-7,10-16 * page 4, paragraph 4 * * page 13, paragraph 3 * * page 26, paragraphs 1-3 * * page 27, paragraph 4 * [I] 8,9;
 [T]WO2011018636  (PCI BIOTECH AS [NO], et al) [T] 1-16 * claim - *;
 [Y]  - CAVALCANTE R S ET AL, "A combination of techniques to evaluate photodynamic efficiency of photosensitizers", LASER PHYSICS LETTERS WILEY-VCH VERLAG GMBH GERMANY, (200901), vol. 6, no. 1, ISSN 1612-2011, pages 64 - 70, XP002636598 [Y] 4 * page 65, column left, paragraph 1 * * page 70, column left, paragraph 2 *

DOI:   http://dx.doi.org/10.1002/LAPL.200810082
 [XI]  - BERG K ET AL, "Site-specific drug delivery by photochemical internalization enhances the antitumor effect of bleomycin", CLINICAL CANCER RESEARCH 20051201 US LNKD- DOI:10.1158/1078-0432.CCR-05-1245, (20051201), vol. 11, no. 23, ISSN 1078-0432, pages 8476 - 8485, XP002636597 [X] 1-7,10-16 * abstract * * page 8477, right-hand column, section "Treatment of xenografts" * [I] 8,9

DOI:   http://dx.doi.org/10.1158/1078-0432.CCR-05-1245
 [T]  - SELBO PAL KRISTIAN ET AL, "Photochemical internalization provides time- and space-controlled endolysosomal escape of therapeutic molecules", JOURNAL OF CONTROLLED RELEASE, (201011), vol. 148, no. 1, Sp. Iss. SI, ISSN 0168-3659, pages 2 - 12, XP002636600 [T] 1-16 * table 1 *

DOI:   http://dx.doi.org/10.1016/J.JCONREL.2010.06.008
ExaminationGB2420784
 WO0244396
by applicantWO9607432
 WO0054708
 WO0244396
 WO0244395
 WO03020309
 US6680301
 US5876989
 GB2420784
 WO0054802
    - BERG, K. ET AL., CANCER RES., (1999), vol. 59, pages 1180 - 1183
    - HOGSET, A. ET AL., HUM. GENE THER., (2000), vol. 11, pages 869 - 880
    - PRASMICKAITE, L. ET AL., J. GENE MED., (2000), vol. 2, pages 477 - 488
    - SELBO, P.K. ET AL., BIOCHIM. BIOPHYS. ACTA, (2000), vol. 1475, pages 307 - 313
    - SELBO, P.K. ET AL., INT. J. CANCER, (2000), vol. 87, pages 853 - 859
    - SELBO, P.K. ET AL., INT. J. CANCER, (2001), vol. 92, pages 761 - 766
    - BERG, K. ET AL., PHOTODYNAMICS NEWS, (2001), vol. 4, pages 2 - 5
    - PRASMICKAITE, L. ET AL., PHOTOCHEM. PHOTOBIOL., (2001), vol. 73, pages 388 - 395
    - SELBO, P.K. ET AL., PHOTOCHEM. PHOTOBIOL., (2001), vol. 74, pages 303 - 310
    - SELBO. P.K. ET AL., TUMOR BIOL., (2002), vol. 23, pages 103 - 112
    - HOGSET, A. ET AL., ADV. DRUG DELIV. REV., (2004), vol. 56, pages 95 - 115
    - BERG, K ET AL., CURR. OPIN. MOL. THER., (2004), vol. 6, pages 279 - 287
    - PRASMICKAITE, L. ET AL., EXPERT OPIN. MOL. THER., (2004), vol. 4, pages 1403 - 1412
    - BERG, K. ET AL., CLIN. CANCER. RES., (2005), vol. 11, pages 8476 - 8485
    - BERG, K. ET AL., CURR. PHARMACOL. BIOTECH, (2006), vol. 8, pages 362 - 372
    - WEYERGANG, A. ET AL., PHOTOCHEM. PHOTOBIOL. SCI., (2008), vol. 7, pages 1032 - 1040
    - CURIEL, D.T., ANN. NEW YORK ACAD. SCI., (1999), vol. 886, pages 158 - 171
    - PENG K.W.; RUSSELL S.J., CURR. OPIN. BIOTECHNOL., (1999), vol. 10, pages 454 - 457
    - WICKHAM T.J., GENE THER., (2000), vol. 7, pages 110 - 114
    - VAN DEN BERGH, CHEMISTRY IN BRITAIN, (198605), pages 430 - 439
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.